Search Results
Novel targeted therapies for NSCLC: Exploring HER2 dysregulation
The Potential of HER2-, HER3-, and TROP2-Targeted Therapies to Address Unmet Needs in Advanced NSCLC
Addressing Key Targets in Advanced NSCLC: HER2-, HER3-, and TROP2-Targeted Therapies
Interim results from DESTINY-Lung01: T-DXd in HER2-overexpressing NSCLC
Developments in targeted lung cancer therapies
Sequencing HER2-targeted therapies in breast cancer
HER2 Mutation Positive NSCLC
Leveraging Targeted Therapies to Improve Outcomes Across the Continuum of HER2+ Breast Cancer
ASCO Lung Cancer Roundtable - NSCLC - Enhertu and the Potential for Treatment of HER2 Positive NSCLC
#ESMO21 Expert Video Report on novelties in metastatic NSCLC
Webinar: HER2-targeted therapies in CCA
Subtypes of EGFR- and HER2-mutant metastatic NSCLC influence response to ICIs
